Home Tags Medicine

medicine Related Content

e-learning

e-learning systems helps healthcare industry manage diabetes changes

An intriguing e-learning programme that helps busy healthcare practitioners stay abreast with changes in diabetes management.
Huntington's Disease

New research suggests Huntington’s Disease may take affect sooner than expected

The National Academy of Sciences (PNAS) has published new research which reveals that Huntington's Disease may take affect in people much earlier on in life than originally expected and that a new drug may be paramount in controlling the disease.
medicine

From molecule to medicine

A report this week from the Office of Health Economics (OHE) shows the amazing impact medicines have had on the NHS and more widely
synergy

Cutting-edge technology synergy in the personalised nanomedicine space: Focus on 3D printing nanomedicines

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision synergy Group explains the role of cutting-edge technology in the personalised nanomedicine space, with a special focus on 3D printing nanomedicines.
Codeine

Codeine revealed as big killer in recent research

The Office for National Statistics has today revealed that the number of drug-related deaths in England and Wales is the highest since records began, with opiate-based prescription painkiller Codeine claiming 20% more lives this year compared to last
blockchain technology platform

HEX innovation introduce blockchain technology platform for medical use

During the Hybrid Summit 2018 in Bangkok, software providers HEX Innovation launched a blockchain platform enabled service to be used by the medical sectors.
new medicine

Type 2 diabetes: Progressing novel scientific insight into new medicine

The gap in the long process of progressing a novel scientific insight into a new medicine is often called “the valley of death”. Read below to understand how the strategic alliance between University of Oxford and Novo Nordisk is aiming to combat type 2 diabetes by bridging this gap.
Type 2 diabetes

Type 2 diabetes in the UK: Priorities for improving patient care

Professor John Wilding from the University of Liverpool charts priorities for improving patient care in the UK when it comes to the prevalent condition, Type 2 diabetes
human health

Nanomedicines: Depicting human health risks hindering clinical translation

Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on the world of nanomedicines, with a special focus on depicting human health risks hindering clinical translation.
Muscular dystrophy

Muscular dystrophy: Present concerns and foreseen opportunities

Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)
commercialisation

The challenge of commercialisation: Keeping an academic balance

Prof Colin J Suckling OBE DSc FRSE, research professor of chemistry at the University of Strathclyde’s Department of Pure & Applied Chemistry shares his views on the challenge of commercialisation when it comes to research into medicinal chemistry

How trusted data is helping to liberate the power of medical cannabis

Bradley Moore, CEO of GCAC discusses how artificial intelligence and blockchain (trusted data) solve the paradox of limited medical cannabis data and anecdotal user information
Cannabis developments

Cannabis developments in North America

Writer, medical cannabis patient, a grower and budtender for GrassRoots Medicinal in Squamish, Caleb McMillan, provides his thoughts on cannabis developments in North America today
medical cannabis advocacy

Medical cannabis advocacy and education

Board Member for Canadians for Fair Access to Medical Marijuana (CFAMM), Peter Thurley, shares his views on medical cannabis advocacy and education issues
e-health

The emergence of personalised e-health care

CEO of Liva Healthcare, Kristoffer From explains the emergence of personalised e-health care and asks if e-health can close the gap between doctors and diabetic patients

Scientists reveal first 3D images of DNA in living human cells

Scientists at the Salk Institute in California have generated the first 3D images of human DNA structure inside living cells

Hospitals to get extra funding to cope with winter pressures

Secretary of State for Health, Jeremy Hunt has announced £20m of extra funding for hospitals to ease pressure on emergency departments ahead of next winter
packaging

Challenging the conventional packaging methods and materials

Angela Morris, CEO, The Wool Packaging Company Ltd talks about challenging pharmaceutical cold chain packaging convention.
regenerative medicine

Transforming regenerative medicine into an opportunity for patients

Antonino Tramonte, Managing Director, Swiss Institute for Regenerative Medicine outlines how regenerative medicine can help patients.
bone regeneration

The benefits of personalised medicine in bone regeneration

Dr. Franz E. Weber, University Zurich's Center of Dental Medicine discusses how personalised medicine can be used in bone regeneration.

Follow Open Access Government